r/OTLK_Investors

Outlook Therapeutics (Nasdaq: $OTLK): The Full LYTENAVA Timeline, The FDA Dispute, And The Real State Of The Story
▲ 8 r/OTLK_Investors+1 crossposts

Outlook Therapeutics (Nasdaq: $OTLK): The Full LYTENAVA Timeline, The FDA Dispute, And The Real State Of The Story

Outlook Therapeutics is not a simple “approval or no approval” biotech story anymore. It is a long regulatory case study around ophthalmic bevacizumab, multiple FDA Complete Response Letters, an approved European/UK product, repeated financing pressure, management resets, and a retail shareholder base trying to understand whether the U.S. file is still alive or structurally blocked.

Evergreen thesis

merlintrader.com
u/Merlin8121 — 1 day ago
▲ 1 r/OTLK_Investors+1 crossposts

2nd Part of the Avastin Story -Off Label abuse in the german Journal "Pharmarecht"

Written by the former president of BAS. That is why they do not generate any significant revenue in Germany. Bob Jahr’s strategy to enter the market alongside Avastin has failed. The only option would have been to take legal action against the off-label use of Avastin. However, Outlook rejected the approach proposed by a consulting firm. That firm had also predicted the disaster. Sales potential for Lytenava alone in Germany: 150 million per year.

Translated with DeepL.com (free version)

u/volleasy — 3 days ago

FDRR Conclusion Decides if OTLK Survives

I’ve been in this stock for years and as with most people, I am extremely disappointed in the management for this company. The survival of this company relies on FDRR conclusion. They are burning money way too quick and eu+uk is not getting the ramp up needed to survive. Praying for literally any outcome except a new full study. Unfortunate, really thought this was a golden goose but as with most things in life, it was too good to be true.

Wondering what y’all are doing with your position? I’m holding about 80% of my shares, sold off the 20% to at least get capital gains losses for taxes.

reddit.com
u/Taipoe — 8 days ago